MicroRNAs go from stop to start

MicroRNAs can both dampen and activate gene expression at different points in the cell cycle, study suggests

Written byJonathan Scheff
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
MicroRNAs, noncoding RNAs widely thought to repress gene expression, can also perform the opposite role of activating translation, according to a study published online today in Science.The study "makes us rethink how microRNA regulates genes," said Phillip Sharp of the Massachusetts Institute of Technology, who was not a coauthor. "By current dogma, all regulation is thought to be negative -- in cancer, immune responses, everything. This is not a small issue, and it's going to be debated."MicroRNAs exert their effects by targeting messenger RNA, and, most researchers hold, repressing protein translation. However, a few previous studies have raised the possibility that microRNAs play an activating role, said Shobha Vasudevan of the Yale University School of Medicine, the lead author of the paper. One study reported that a microRNA found in the human liver increased replication of RNA of the Hepatitis C virus (HCV), presumably by activating gene expression.Vasudevan and her colleagues stumbled upon the current findings while investigating how gene expression is activated. Their previous work had shown that adenylate/uridylate-rich elements (AREs), conserved sequences on many messenger RNAs, form a complex with two proteins to activate translation. Since these proteins are known to be involved in microRNA functioning, they examined the role of microRNA in translational activation by ARE. They found that the ability of AREs to associate with the two proteins depended on a microRNA (miR369-3). They also found that miR369-3 activated translation only after the cell cycle stopped. During the cell cycle, while the cell was proliferating, the microRNA down-regulated translational activity, but upon cell-cycle arrest, it reversed its effect.The group then examined two other microRNAs to see if this process occurred more widely. Both also demonstrated oscillation between regulation and activation over the course of the cell cycle.Vasudevan noted that they do not yet understand the mechanism that differentially triggers activation or repression. Also, this oscillation is yet to be observed in vivo. "[Our study] opens up more avenues for research," she said, by "adding new functions to something previously described as a repressor."Greg Hannon of the Cold Spring Harbor Laboratory, who was not involved in the work, agreed that future studies would have to determine the biochemical mechanism of this phenomenon and determine whether it occurs in vivo. Still, he said, the study "really changes the way we have to think about microRNA targets." Jonathan Scheff mail@the-scientist.comCorrection (posted Dec. 10): A previous version of this article mistakenly stated that microRNAs activate transcription instead of translation. The Scientist regrets the error. Links within this article:D. Steinberg, "MicroRNA Shows Macro Potential," The Scientist, June 16, 2003.
http://www.the-scientist.com/article/display/13871/The Scientist Staff, "The RNA Conductome," The Scientist, Sept. 2007. http://www.the-scientist.com/2007/10/1/55/1/S. Vasudevan et al., "Switching from repression to activation: microRNAs can up-regulate translation," Sciencexpress, Nov. 29, 2007. http://www.sciencexpress.orgPhillip Sharp http://web.mit.edu/sharplab/C.Q. Choi, "A New View of Translational Control," The Scientist, Dec. 5, 2005. http://www.the-scientist.com/article/display/15897/A. Goodman et al., "The Uncertain Future for Central Dogma," The Scientist, June 20, 2005. http://www.the-scientist.com/article/display/15540/C. Jopling et al., "Modulation of Hepatitis C virus RNA abundance by a liver-specific microRNA," Science, Sept. 2, 2005. http://www.the-scientist.com/pubmed/16141076S. Vasudevan and J. Steitz, "AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2," Cell, March 23, 2007. http://www.the-scientist.com/pubmed/17382880Greg Hannon http://gradschool.cshl.edu/hannon_.html
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026, Issue 1

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs
Graphic of three DNA helices in various colors

An Automated DNA-to-Data Framework for Production-Scale Sequencing

illumina
Exploring Cellular Organization with Spatial Proteomics

Exploring Cellular Organization with Spatial Proteomics

Abstract illustration of spheres with multiple layers, representing endoderm, ectoderm, and mesoderm derived organoids

Organoid Origins and How to Grow Them

Thermo Fisher Logo

Products

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control

Biotium Logo

Biotium Launches GlycoLiner™ Cell Surface Glycoprotein Labeling Kits for Rapid and Selective Cell Surface Imaging

Colorful abstract spiral dot pattern on a black background

Thermo Scientific X and S Series General Purpose Centrifuges

Thermo Fisher Logo
Abstract background with red and blue laser lights

VANTAstar Flexible microplate reader with simplified workflows

BMG LABTECH